PROFITABLE DNA NUTRITION PLATFORM, 10,000 USERS, 59% SDE MARGIN
Listing Number: 60091-904075
Listing Details
- Down Payment: $1,199,000
- Sales: $546,313
- Seller's Discretionary Earnings: $318,521
- Inventory: $4,000
- Furniture, Fixtures, and Equipment: $0
- Employees: 0
- Year Established: 2018
- Reason for Selling: Other Personal Interests

Business Description
A profitable, founder-built precision-nutrition platform that has sold its core product every day for eight years.
The company translates a customer's DNA into a practical, personalized way of eating. A proprietary algorithm classifies each customer into one of twenty named diet types, then generates a personalized meal plan and nutrition protocol built around how that individual actually metabolizes fat, carbohydrate, protein, caffeine, histamine, and dietary cholesterol. On top of that core sits a growing library of premium health reports — cardiovascular, methylation, micronutrient, longevity, sleep, and more — sold as an annual membership currently held by approximately 1,000 members, plus a branded supplement line matched to the genetic results.
This is a product with demonstrated durable product-market fit. It launched in 2018, has served thousands of customers, and has generated revenue continuously since. The twenty-diet-type framework is what customers connect with, talk about, and return for: an identity and a plan rather than a raw data dump. Customer acquisition runs on SEO, organic search, email, and word of mouth, supported by HSA/FSA eligibility and inbound demand from clinics and integrative-medicine practitioners.
The business is profitable and capital efficient. Revenue grew from under $60,000 to $555,300 in three years while remaining profitable every year. In 2025 it generated $327,200 in seller's discretionary earnings — a 59% SDE margin — on a fully remote operation with no full-time employees and approximately 79% gross margins.
The platform has also proven it can extend. A 2025 supplement line and a 2026 environmental-genomics release were both built and shipped on modest budgets using the existing architecture, and a consented research cohort has been accumulating alongside the core business. These represent optionality on top of a proven cash-generating core.
Highlights:
- $555,300 revenue in 2025 | $327,200 SDE | ~79% gross margins
- Eight consecutive years of sales on the core DNA nutrition product, launched 2018
- ~110% three-year revenue CAGR (FY22 $58.5K → FY25 $555.3K); SDE up from $29.9K to $327.2K
- Proprietary twenty-diet-type taxonomy built on 200+ vetted genetic factors, each carrying an internal Science Grade derived from a two-year peer-reviewed literature review
- AI engine generating personalized meal plans and nutrition protocols directly from genetic results
- Approximately 1,000 members paying annual fees — an established subscription layer built without a dedicated conversion program
- Two acquisition paths into the core product: physical test kits fulfilled through a CLIA-certified lab, and near-zero-COGS analysis of raw data uploaded from 23andMe and Ancestry
- 2025 supplement line with repeat-purchase behavior
- Demonstrated B2B demand from wellness clinics, IV clinics, functional-medicine providers, and physicians
- Strong SEO, low CAC, HSA/FSA eligible
- Lean and remote: owner part-time plus four independent contractors, no physical overhead
- Consented, transferable genome + environment research dataset — a monetization path not yet activated
